Details of the Drug Reposition

General Information of This Drug (ID: DMVZT2I)

Drug Name
CX-072   DMVZT2I
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Medulloblastoma DISZD2ZL 2A00.10 Phase 2 [1]
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Lymphoma DISN6V4S 2A80-2A86 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway.J Med Chem. 2019 Feb 28;62(4):1715-1730.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)